Clinical Trial Update: Glatiramer Acetate for Multiple Sclerosis With Autoimmune Comorbidities

View source ↗

Summary

A completed clinical trial evaluating glatiramer acetate in relapsing-remitting multiple sclerosis, including participants with autoimmune comorbidities.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• GLATIRAMER ACETATE (GLATIRAMER ACETATE)

Snippet

Sponsor: University of Southern California | Conditions: Relapsing Remitting Multiple Sclerosis | Status: COMPLETED